Assistant Professor
BIOGRAPHY
SEP 07, 2022 10:00 AM PDT
Novel therapeutic approach to lethal SARS-CoV-2 infection in aged murine models
Speaker
Event Date & Time
Date: September 07, 2022
Time: 10:00 am (PDT), 1:00 pm (EDT), 7:00 pm (CEST)
Abstract
Severe acute respiratory syndrome coronavirus (SARS-CoV-2), the infection that causes COVID-19, is especially severe in older populations. The development of SARS-CoV-2 vaccines has helped advance a resolution to the COVID-19 pandemic but their efficacy is partly compromised by the recent emergence of variants with enhanced transmissibility. The emergence of these variants emphasizes the need for further development of anti-SARS-CoV-2 therapies, especially in aged populations.
Learning objectives
- How to use murine SARS-CoV-2 infection models to study COVID-19 pathogenesis
- Understand the role of PLA2G2D, a phospholipase, and its downstream lipid product, prostaglandin D2 (PGD2) in the pathogenesis of SARS-CoV-2 infection
- Explore the potential of PLA2G2D-PGD2/PTGDR pathway-targeting COVID-19 therapies by using Asapiprant, a PTGDR antagonist
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
Loading Comments...